High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up. [electronic resource]
Producer: 20120320Description: 261-8 p. digitalISSN:- 1479-683X
- Adrenal Cortex Neoplasms -- blood
- Adrenocortical Carcinoma -- blood
- Adult
- Aged
- Antineoplastic Agents, Hormonal -- administration & dosage
- Blood Chemical Analysis
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Mitotane -- administration & dosage
- Osmolar Concentration
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.